FDA NDC Directory · JSON-LD · Markdown

Hydroxyzine Pamoate

NDC 51655-252 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerNorthwind Health Company, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA088487
Dosage form / routeCAPSULE · ORAL
Active ingredientsHYDROXYZINE PAMOATE (50 mg/1)
Marketing started20230425
Package count1

External sources

Source: openFDA. Public-domain (CC0).